Qualigen Therapeutics Inc (QLGN)


Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Qualigen Therapeutics Inc chart...

About the Company

We do not have any company description for Qualigen Therapeutics Inc at the moment.

Please visit https://www.qualigeninc.com/ for more information about the company.

CEO

Andrew Ritter

Exchange

NASDAQ

Website

https://www.qualigeninc.com/

$22M

Total Revenue

36

Employees

$2M

Market Capitalization

-0.31

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $QLGN News

Qualigen Therapeutics Inc (QLGN)

1d ago, source: Investing

For Immediate ReleaseChicago, IL –August 11, 2017 - Stocks in this week’s article include Post Holdings Inc. (NYSE: (NYSE:POST) – Free Report), Duluth Holdings ...

APVO Aptevo Therapeutics Inc.

1d ago, source: Seeking Alpha

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company ...

Qualigen Therapeutics Inc Ordinary Shares QLGN

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Qualigen Therapeutics Inc Ordinary Shares

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Qualigen Therapeutics Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Qualigen Therapeutics, Inc. Common Stock (QLGN)

8y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Qualigen Therapeutics Inc (QLGN)

1y ago, source: Investing

Qualigen Therapeutics, Inc. (QLGN) reported Q2 EPS of ($0.11), $0.05 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.4 million versus the ...

Qualigen Therapeutics, Inc. (QLGN)

3y ago, source: Yahoo Finance

*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Qualigen Therapeutics Inc (QLGN)

27d ago, source: Investing

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug... Qualigen ...

Qualigen Therapeutics Inc (QLGN)

1mon ago, source: Investing

Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Oil & Gas, Technology and Financials sectors propelled shares higher while losses in the Basic... Investing.com – ...

Qualigen Therapeutics, Inc. (QLGN)

1y ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...